Probiotic Lactobacillus Strains Stimulate the Inflammatory Response and Activate Human Macrophages

Journal of Immunology Research

Volumn 2017, Issue , 2017, Pages

  Rocha Ramirez L M ^a   Perez Solano R A ^a   Castanon Alonso S L ^a   Moreno Guerrero, S S ^a   Ramirez Pacheco A ^a   Garcia Garibay M ^b   Eslava, C ^a  

^a HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^b DEPARTAMENTO DE QUÍMICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PROBIOTIC AGENT; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 2; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR; ZYMOSAN; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12;

ARTICLE; BACTERIAL CELL; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ESCHERICHIA COLI; HEK293 CELL LINE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INNATE IMMUNITY; LACTOBACILLUS; LACTOBACILLUS CASEI; LACTOBACILLUS HELVETICUS; LACTOBACILLUS RHAMNOSUS; MACROPHAGE; MOLECULAR RECOGNITION; NONHUMAN; PHAGOCYTOSIS; PROTEIN EXPRESSION; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; STAPHYLOCOCCUS AUREUS; BIOSYNTHESIS; CELL CULTURE; IMMUNOLOGY; INFLAMMATION; MACROPHAGE ACTIVATION; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

CELLS, CULTURED; CYTOKINES; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INTERLEUKIN-12; INTERLEUKIN-6; INTERLEUKIN-8; LACTOBACILLUS; LACTOBACILLUS RHAMNOSUS; MACROPHAGE ACTIVATION; NF-KAPPA B; PHAGOCYTOSIS; PROBIOTICS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85025105826     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2017/4607491     Document Type: Article

References (43)

1. G. Reid and Food and Agricultural Organization of the United Nation and the WHO, "The importance of guidelines in the development and application of probiotics," Current Pharmaceutical Design, vol. 11, no. 1, pp. 11-16, 2005.
2. V. Delcenserie, D. Martel, M. Lamoureux, J. Amiot, Y. Boutin, and D. Roy, "Immunomodulatory effects of probiotics in the intestinal tract," Current Issues in Molecular Biology, vol. 10, no. 1-2, pp. 37-54, 2008.
3. J. A. Vanderhoof and S. H. Mitmesser, "Probiotics in the management of children with allergy and other disorders of intestinal inflammation," Beneficial Microbes, vol. 1, no. 4, pp. 352-356, 2010.
4. A. F. Nixon, S. J. Cunningham, H. W. Cohen, and E. F. Crain, "The effect of lactobacillus GG on acute diarrheal illness in the pediatric emergency department," Pediatric Emergency Care, vol. 29, no. 10, pp. 1048-1051, 2012.
5. O. Gillor, A. Etzion, and M. A. Riley, "The dual role of bacteriocins as anti-and probiotics," Applied Microbiology and Biotechnology, vol. 81, no. 4, pp. 591-560, 2008.
6. Robinson J1., "Cochrane in context: probiotics for prevention of necrotizing enterocolitis in preterm infants," Evidence-Based Child Health, vol. 9, no. 3, pp. 672-674, 2014.
7. C. E. West, M. L. Hammarström, and O. Hernell, "Probiotics in primary prevention of allergic disease-follow-up at 8-9 years of age," Allergy, vol. 68, no. 8, pp. 1015-1020, 2013.
8. J. Grimoud, H. Durand, S. de Souza et al., "In vitro screening of probiotics and synbiotics according to anti-inflammatory and anti-proliferative effects," International Journal of Food Microbiology, vol. 144, no. 1, pp. 42-50, 2010.
9. H. Jensen, S. M. Drømtorp, L. Axelsson, and S. Grimmer, "Immunomodulation of monocytes by probiotic and selected lactic acid bacteria," Probiotics Antimicrobial Proteins, vol. 7, no. 1, pp. 14-24, 2015.
10. M. Lopez, N. Li, J. Kataria, M. Russell, and J. Neu, "Live and ultraviolet-inactivated Lactobacillus rhamnosus GG decrease flagellin-induced interleukin-8 production in Caco-2 cells," The Journal of Nutrition, vol. 138, no. 11, pp. 2264-2268, 2008.
11. N. Li, W. M. Russell, M. Douglas-escobar, N. Hauser, M. Lopez, and J. Neu, "Live and heat-killed Lactobacillus rhamnosus GG: effects on proinflammatory and anti-inflammatory cytokines/chemokines in gastrostomy-fed infant rats," Pediatric Research, vol. 66, no. 2, pp. 203-207, 2009.
12. Y. Zhang, L. Zhang, M. Du et al., "Antimicrobial activity against Shigellasonnei and probiotic properties of wild lactobacillus from fermented food," Microbiological Research, vol. 167, no. 1, pp. 27-32, 2011.
13. N. Habil, W. Al-Murrani, J. Beal, and A. D. Foey, "Probiotic bacterial strains differentially modulate macrophage cytokine production in a strain-dependent and cell subsetspecific manner," Beneficial Microbes, vol. 2, no. 4, pp. 283-293, 2011.
14. N. Suzuki and R. Mittler, "Reactive oxygen species-dependent wound responses in animals and plants," Free Radical Biology and Medicine, vol. 53, no. 12, pp. 2269-2276, 2012.
15. L. Franken, M. Schiwon, and C. Kurts, "Macrophages: sentinels and regulators of the immune system," Cellular Microbiology, vol. 18, no. 4, pp. 475-487, 2016.
16. S. Lebeer, J. Vanderleyden, and S. C. De Keersmaecker, "Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens," Nature Reviews. Microbiology, vol. 8, no. 3, pp. 171-184, 2010.
17. D. S. O'Mahony, U. Pham, R. Iyer, T. R. Hawn, and W. C. Liles, "Differential constitutive and cytokine-modulated expression of human Toll-like receptors in primary neutrophils, monocytes, and macrophages," International Journal of Medicine Sciences, vol. 5, no. 1, pp. 1-8, 2008.
18. M. M. Rahman and G. McFadden, "Modulation of NFB signalling by microbial pathogens," Nature Reviews. Microbiology, vol. 9, no. 4, pp. 291-306, 2011.
19. M. Miettinen, A. Lehtonen, I. Julkunen, and S. Matikainen, "Lactobacilli and Streptococci activate NF-kappa B and STAT signaling pathways in human macrophages," Journal of Immunology, vol. 164, no. 7, pp. 3733-3740, 2000.
20. A. Cruz-Guerrero, H. Hernández-Sánchez, G. Rodríguez-Serrano, L. Gómez-Ruiz, M. García-Garibay, and I. Figueroa-González, "Commercial probiotic bacteria and prebiotic carbohydrates: a fundamental study on prebiotics uptake, antimicrobials production and inhibition of pathogens," Journal of the Science of Food and Agriculture, vol. 94, no. 11, pp. 2246-2252, 2014.
21. Y. Escamilla-Lozano, M. García-Garibay, A. López-Munguía-Canales, L. Gómez-Ruiz, G. Rodríguez-Serrano, and A. Cruz-Guerrero, "Synthesis of a-l-fucosidase in different strains of lactic acid bacteria," Revista Mexicana de Ingeniería Química, vol. 14, no. 3, pp. 623-629, 2015.
22. L. M. Rocha-Ramírez, U. Hernández-Chiñas, D. Baños-Rojas et al., "Pet serine protease from enteroaggregative Escherichia coli stimulates the inflammatory response activating human macrophages," BMC Microbiology, vol. 16, no. 1, p. 158, 2016.
23. P. Rellstab and A. Schaffner, "Endotoxin suppresses the generation of O2-and H2O2 by resting and lymphokine-activated human blood-derived macrophages," Journal of Immunology, vol. 142, no. 8, pp. 2813-2820, 1989.
24. T. M. Stevanin, R. K. Poole, E. A. Demoncheaux, and R. C. Read, "Flavohemoglobin Hmp protects Salmonella enterica serovar typhimurium from nitric oxide-related killing by human macrophages," Infection and Immunity, vol. 70, no. 8, pp. 4399-4405, 2002.
25. T. T. MacDonald, I. Monteleone, M. C. Fantini, and G. Monteleone, "Regulation of homeostasis and inflammation in the intestine," Gastroenterology, vol. 140, no. 6, pp. 1768-1775, 2011.
26. P. P. van Lierop, J. N. Samsom, J. C. Escher, and E. E. Nieuwenhuis, "Role of the innate immune system in the pathogenesis of inflammatory bowel disease," Journal of Pediatric Gastroenterology and Nutrition, vol. 48, no. 2, pp. 142-151, 2009.
27. F. C. Fang, "Antimicrobial actions of reactive oxygen species," MBio, vol. 2, no. 5, pp. e00141-e00111, 2011.
28. J. Marcinkiewicz, M. Ciszek, M. Bobek et al., "Differential inflammatory mediator response in vitro from murine macrophages to lactobacilli and pathogenic intestinal bacteria," International Journal of Experimental Pathology, vol. 88, no. 3, pp. 155-164, 2007.
29. S. Ichikawa, M. Miyake, R. Fujii, and Y. Konishi, "MyD88 associated ROS generation is crucial for Lactobacillus induced IL-12 production in macrophage," PLoS One, vol. 7, no. 4. article e35880, 2012.
30. J. Sun, X. L. Hu, G. W. Le, and Y. H. Shi, "Lactobacilli prevent hydroxy radical production and inhibit Escherichia coli and Enterococcus growth in system mimicking colon fermentation," Letters in Applied Microbiology, vol. 50, no. 3, pp. 264-269, 2010.
31. P. Forsythe and J. Bienenstock, "Immunomodulation by commensal and probiotic bacteria," Immunological Investigations, vol. 39, no. 4-5, pp. 429-448, 2010.
32. J. W. Griffith, C. L. Sokol, and A. D. Luster, "Chemokines and chemokine receptors positioning cells for host defense and immunity," Annual Review of Immunology, vol. 32, pp. 659-702, 2014.
33. V. Veckman, M. Miettinen, S. Matikainen et al., "Lactobacilli and streptococci induce inflammatory chemokine production in human macrophages that stimulates Th1 cell chemotaxis," Journal of Leukocyte Biology, vol. 74, no. 3, pp. 395-402, 2003.
34. Y. Jiang, X. Lü, C. Man et al., "Lactobacillus acidophilus induces cytokine and chemokine production via NFB and p38 mitogen-activated protein kinase signaling pathways in intestinal epithelial cells," Clinical and Vaccine Immunology, vol. 19, no. 4, pp. 603-608, 2012.
35. S. P. Commins, L. Borish, and J. W. Steinke, "Immunologic messenger molecules: cytokines, interferons, and chemokines," Journal of Allergy and Clinical Immunology, vol. 125, Supplement 2, pp. S53-S72, 2010.
36. A. De Moreno de LeBlanc, S. del Carmen, M. Zurita-Turk et al., "Importance of IL-10 modulation by probiotic microorganisms in gastrointestinal inflammatory diseases," ISR Gastroenterology, vol. 2011, p. 892971, 2011.
37. D. Ren, C. Li, Y. Qin et al., "Evaluation of immunomodulatory activity of two potential probiotic Lactobacillus strains by in vivo tests," Anaerobe, vol. 35, no. Part B, pp. 22-27, 2015.
38. D. Kaushal and V. K. Kansal, "Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum improves phagocytic potential of macrophages in aged mice," Journal of Food Science and Technology, vol. 51, no. 6, pp. 1147-1153, 2014.
39. J. Napetschnig and H. Wu, "Molecular basis of NFB signaling," Annual Review of Biophysics, vol. 42, pp. 443-448, 2013.
40. Y. G. Kim, T. Ohta, T. Takahashi et al., "Probiotic Lactobacillus casei activates innate immunity via NF-kappa B and p38 MAP kinase signaling pathways," Microbes and Infection, vol. 8, no. 4, pp. 994-1005, 2006.
41. K. Shida, J. Kiyoshima-Shibata, R. Kaji, M. Nagaoka, and M. Nanno, "Peptidoglycan from lactobacilli inhibits interleukin-12 production by macrophages induced by Lactobacillus casei through Toll-like receptor 2-dependent and independent mechanisms," Immunology, vol. 128, 1 Supplement, pp. 858-869, 2009.
42. R. Kaji, J. Kiyoshima-Shibata, M. Nagaoka, M. Nanno, and K. Shida, "Bacterial teichoic acids reverse predominant IL-12 production induced by certain lactobacillus strains into predominant IL-10 production via TLR2-dependent ERK activation in macrophages," Journal of Immunology, vol. 184, no. 7, pp. 3505-3513, 2010.
43. S. Cai, B. H. Bay, Y. K. Lee, J. Lu, and R. Mahendran, "Live and lyophilized Lactobacillus species elicit differential immunomodulatory effects on immune cells," FEMS Microbiology Letters, vol. 302, no. 2, pp. 189-196, 2010.